| For: | Almomani A, Hitawala AA, Kumar P, Alqaisi S, Alshaikh D, Alkhayyat M, Asaad I. Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study. World J Hepatol 2022; 14(3): 551-558 [PMID: 35582287 DOI: 10.4254/wjh.v14.i3.551] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i3/551.htm |
| Number | Citing Articles |
| 1 |
Bo Chen, Shaobo Wang, Yali Huang, Deqing Liu, Runjie Chen, Hua Zhang, Wenying Wang, Qian Zhou, Liuqi Lie, Jianmin Ran, Gugen Xu. Current status of hypothyroidism control in Guangzhou area, China: a cross-sectional survey. BMC Endocrine Disorders 2026; 26(1) doi: 10.1186/s12902-026-02214-0
|
| 2 |
Antoine Boustany, Somtochukwu Onwuzo, Hadi Khaled Abou Zeid, Ashraf Almomani, Prabhat Kumar, Asif Hitawala, Imad Asaad. Non‐alcoholic steatohepatitis is independently associated with a history of gestational diabetes mellitus. Journal of Gastroenterology and Hepatology 2023; 38(6) doi: 10.1111/jgh.16163
|
| 3 |
Yan Zhao, Xin-Quan Wu, Pan Luo, Shu-Li Liao. Significant association of sensitivity to thyroid hormones with liver fibrosis: Analysis based on NHANES data. Arab Journal of Gastroenterology 2025; 26(4) doi: 10.1016/j.ajg.2025.09.001
|
| 4 |
Shyam Chand Chaudhary, Pankhuri Singh, Kauser Usman, Kamal Kumar Sawlani, Kamlesh Kumar Gupta, Vivek Kumar, Munna Lal Patel, Amit Kumar Gupta, Sumit Rungta, Anit Parihar. Hypothyroidism in Nonalcoholic Fatty Liver Disease. Journal of The Association of Physicians of India 2026; 74(6) doi: 10.59556/japi.74.1502
|
| 5 |
O. A. Polyviana, E. V. Stetsuk, V. I. Shepitko, O. V. Vilkhova, N. V. Boruta, M. V. Rud, L. B. Pelypenko, O. D. Lysachenko, O. V. Voloshyna, I. L. Dvornyk, H. Yu. Morokhovets. Studies of changes in rat hepatocytes under conditions of central blockade of luteinizing hormone synthesis with the additional quercetin. Reports of Morphology 2025; 31(1) doi: 10.31393/morphology-journal-2025-31(1)-07
|
| 6 |
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher. Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut 2024; 73(9) doi: 10.1136/gutjnl-2024-332491
|
| 7 |
Peng Wang, Heli Zhang, Jing Wang, Ying Che, Lin Zhuo, Miao Yu, Xianjing Hu, Peitao Li, Rongmei Geng, Siyan Zhan, Baohua Li. Metabolic Disease and Risk of Thyroid Disease: Evidence from the National Nurse Health Cohort in China. Biological Research For Nursing 2023; 25(4) doi: 10.1177/10998004231177297
|
| 8 |
Liyuan Zhou, Yun Yu, Lanxuan Jiang, Jia Liu, Guang Wang. Intermittent fasting-induced amelioration of thyroid hormone sensitivity was associated with improvements in insulin sensitivity independent of weight loss in steatotic liver disease. Metabolism and Target Organ Damage 2025; 5(3) doi: 10.20517/mtod.2025.99
|
| 9 |
Leonidas H. Duntas, Stergios A. Polyzos, Ulrike Gottwald-Hostalek, Bogumila Urgatz, Paul M. Yen. Repurposing levothyroxine for managing metabolic dysfunction-associated steatotic liver disease. Endocrine 2025; 90(3) doi: 10.1007/s12020-025-04451-0
|
| 10 |
Paulina Vidal-Cevallos, Sofía Murúa-Beltrán Gall, Misael Uribe, Norberto C. Chávez-Tapia. Understanding the Relationship between Nonalcoholic Fatty Liver Disease and Thyroid Disease. International Journal of Molecular Sciences 2023; 24(19) doi: 10.3390/ijms241914605
|
| 11 |
Mohamed W. Saleh, Maysa I. Farghly, Eman Elsebaie, Nessren Mohamed, Eman El-Mankhly. Impact of thyroid dysfunction and diabetes on fibrosis and steatosis stages in metabolic dysfunction associated fatty liver disease. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-28232-x
|